Category

Patents

1,278 articles

Strategic Delay Costs Novartis Its Cross-Examination Rights

The Delhi High Court dismissed Novartis’s writ petitions, ruling it had waived cross-examination by opting for rebuttal evidence. The Controller’s orders were upheld, with the patent already revoked…

Neetha Mohan · 23 Sep 2025